CA3099238A1 - Systeme de surveillance cerebrale - Google Patents
Systeme de surveillance cerebrale Download PDFInfo
- Publication number
- CA3099238A1 CA3099238A1 CA3099238A CA3099238A CA3099238A1 CA 3099238 A1 CA3099238 A1 CA 3099238A1 CA 3099238 A CA3099238 A CA 3099238A CA 3099238 A CA3099238 A CA 3099238A CA 3099238 A1 CA3099238 A1 CA 3099238A1
- Authority
- CA
- Canada
- Prior art keywords
- light
- oct
- faf
- headset
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000012544 monitoring process Methods 0.000 title description 12
- 210000004556 brain Anatomy 0.000 title description 7
- 238000000034 method Methods 0.000 claims abstract description 42
- 238000003384 imaging method Methods 0.000 claims description 39
- 230000008569 process Effects 0.000 claims description 24
- 238000012545 processing Methods 0.000 claims description 22
- 239000000835 fiber Substances 0.000 claims description 17
- 230000005284 excitation Effects 0.000 claims description 14
- 230000004888 barrier function Effects 0.000 claims description 11
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 4
- 238000005253 cladding Methods 0.000 claims description 4
- 238000004891 communication Methods 0.000 claims description 4
- 210000003128 head Anatomy 0.000 claims description 4
- 229910052709 silver Inorganic materials 0.000 claims description 4
- 239000004332 silver Substances 0.000 claims description 4
- 230000003068 static effect Effects 0.000 claims description 4
- 206010061218 Inflammation Diseases 0.000 abstract description 19
- 230000004054 inflammatory process Effects 0.000 abstract description 19
- 230000037444 atrophy Effects 0.000 abstract description 8
- 206010003694 Atrophy Diseases 0.000 abstract description 5
- 238000012014 optical coherence tomography Methods 0.000 description 106
- 210000001525 retina Anatomy 0.000 description 42
- 230000002207 retinal effect Effects 0.000 description 36
- 201000006417 multiple sclerosis Diseases 0.000 description 23
- 230000009266 disease activity Effects 0.000 description 16
- 229940079593 drug Drugs 0.000 description 16
- 239000003814 drug Substances 0.000 description 16
- 230000033001 locomotion Effects 0.000 description 14
- 208000024891 symptom Diseases 0.000 description 14
- 238000004458 analytical method Methods 0.000 description 13
- 230000008859 change Effects 0.000 description 13
- 238000007781 pre-processing Methods 0.000 description 12
- 239000000047 product Substances 0.000 description 11
- 230000004286 retinal pathology Effects 0.000 description 11
- 230000003287 optical effect Effects 0.000 description 9
- 210000003169 central nervous system Anatomy 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 230000001965 increasing effect Effects 0.000 description 8
- 238000005259 measurement Methods 0.000 description 8
- 238000012634 optical imaging Methods 0.000 description 8
- 238000012805 post-processing Methods 0.000 description 8
- 238000011282 treatment Methods 0.000 description 8
- 201000010099 disease Diseases 0.000 description 7
- 238000003860 storage Methods 0.000 description 7
- 208000036110 Neuroinflammatory disease Diseases 0.000 description 6
- 238000013461 design Methods 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- 230000004424 eye movement Effects 0.000 description 6
- 238000004806 packaging method and process Methods 0.000 description 6
- 210000001747 pupil Anatomy 0.000 description 6
- 230000001360 synchronised effect Effects 0.000 description 6
- 238000012546 transfer Methods 0.000 description 6
- 208000007400 Relapsing-Remitting Multiple Sclerosis Diseases 0.000 description 5
- 230000005540 biological transmission Effects 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 230000002757 inflammatory effect Effects 0.000 description 5
- 230000004770 neurodegeneration Effects 0.000 description 5
- 230000003959 neuroinflammation Effects 0.000 description 5
- 238000002560 therapeutic procedure Methods 0.000 description 5
- 206010010904 Convulsion Diseases 0.000 description 4
- 230000001133 acceleration Effects 0.000 description 4
- 206010064930 age-related macular degeneration Diseases 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000010191 image analysis Methods 0.000 description 4
- 230000037361 pathway Effects 0.000 description 4
- 230000000007 visual effect Effects 0.000 description 4
- 208000007333 Brain Concussion Diseases 0.000 description 3
- 208000024806 Brain atrophy Diseases 0.000 description 3
- 208000010412 Glaucoma Diseases 0.000 description 3
- 208000012902 Nervous system disease Diseases 0.000 description 3
- 208000025966 Neurological disease Diseases 0.000 description 3
- 208000017442 Retinal disease Diseases 0.000 description 3
- 208000030886 Traumatic Brain injury Diseases 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 208000025698 brain inflammatory disease Diseases 0.000 description 3
- 238000010219 correlation analysis Methods 0.000 description 3
- 230000001054 cortical effect Effects 0.000 description 3
- 230000007850 degeneration Effects 0.000 description 3
- 206010014599 encephalitis Diseases 0.000 description 3
- 206010015037 epilepsy Diseases 0.000 description 3
- 230000028993 immune response Effects 0.000 description 3
- 238000002483 medication Methods 0.000 description 3
- 230000002911 mydriatic effect Effects 0.000 description 3
- 230000007170 pathology Effects 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 230000035939 shock Effects 0.000 description 3
- 230000009529 traumatic brain injury Effects 0.000 description 3
- 238000011269 treatment regimen Methods 0.000 description 3
- 102000014461 Ataxins Human genes 0.000 description 2
- 108010078286 Ataxins Proteins 0.000 description 2
- 206010008025 Cerebellar ataxia Diseases 0.000 description 2
- 206010071068 Clinically isolated syndrome Diseases 0.000 description 2
- 206010012689 Diabetic retinopathy Diseases 0.000 description 2
- 206010061818 Disease progression Diseases 0.000 description 2
- 208000008069 Geographic Atrophy Diseases 0.000 description 2
- 208000023105 Huntington disease Diseases 0.000 description 2
- 208000003435 Optic Neuritis Diseases 0.000 description 2
- 208000009415 Spinocerebellar Ataxias Diseases 0.000 description 2
- 208000037114 Symptom Flare Up Diseases 0.000 description 2
- 208000002552 acute disseminated encephalomyelitis Diseases 0.000 description 2
- VREFGVBLTWBCJP-UHFFFAOYSA-N alprazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1 VREFGVBLTWBCJP-UHFFFAOYSA-N 0.000 description 2
- 206010002026 amyotrophic lateral sclerosis Diseases 0.000 description 2
- 201000004562 autosomal dominant cerebellar ataxia Diseases 0.000 description 2
- 230000036995 brain health Effects 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000007405 data analysis Methods 0.000 description 2
- 238000013500 data storage Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000005750 disease progression Effects 0.000 description 2
- 239000002270 dispersing agent Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 208000002780 macular degeneration Diseases 0.000 description 2
- 238000002595 magnetic resonance imaging Methods 0.000 description 2
- 238000013507 mapping Methods 0.000 description 2
- 208000005264 motor neuron disease Diseases 0.000 description 2
- 208000015122 neurodegenerative disease Diseases 0.000 description 2
- 208000008795 neuromyelitis optica Diseases 0.000 description 2
- 238000010606 normalization Methods 0.000 description 2
- 238000004393 prognosis Methods 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 230000003252 repetitive effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 201000008628 secondary progressive multiple sclerosis Diseases 0.000 description 2
- 230000011218 segmentation Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 208000002320 spinal muscular atrophy Diseases 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 230000002123 temporal effect Effects 0.000 description 2
- 239000012780 transparent material Substances 0.000 description 2
- 230000001755 vocal effect Effects 0.000 description 2
- 208000007848 Alcoholism Diseases 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 208000014644 Brain disease Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 206010012688 Diabetic retinal oedema Diseases 0.000 description 1
- 206010013654 Drug abuse Diseases 0.000 description 1
- 241000027036 Hippa Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 101150036663 Nr2e3 gene Proteins 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 208000024777 Prion disease Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 206010038933 Retinopathy of prematurity Diseases 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 241000482268 Zea mays subsp. mays Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 210000001642 activated microglia Anatomy 0.000 description 1
- 206010001584 alcohol abuse Diseases 0.000 description 1
- 208000025746 alcohol use disease Diseases 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000003376 axonal effect Effects 0.000 description 1
- 230000007845 axonopathy Effects 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000006931 brain damage Effects 0.000 description 1
- 231100000874 brain damage Toxicity 0.000 description 1
- 208000029028 brain injury Diseases 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 208000037893 chronic inflammatory disorder Diseases 0.000 description 1
- 230000001149 cognitive effect Effects 0.000 description 1
- 230000009514 concussion Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000013481 data capture Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 201000011190 diabetic macular edema Diseases 0.000 description 1
- 238000002059 diagnostic imaging Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000003708 edge detection Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 208000028329 epileptic seizure Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000005713 exacerbation Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 231100000040 eye damage Toxicity 0.000 description 1
- 210000000887 face Anatomy 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 229940125721 immunosuppressive agent Drugs 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 238000005305 interferometry Methods 0.000 description 1
- 238000009449 lightweight packaging Methods 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000010801 machine learning Methods 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000002025 microglial effect Effects 0.000 description 1
- 230000006775 microglial inflammation Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003007 myelin sheath Anatomy 0.000 description 1
- 210000004126 nerve fiber Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000000626 neurodegenerative effect Effects 0.000 description 1
- 238000002610 neuroimaging Methods 0.000 description 1
- 230000002314 neuroinflammatory effect Effects 0.000 description 1
- 230000003962 neuroinflammatory response Effects 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 230000003961 neuronal insult Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000010408 sweeping Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 208000009174 transverse myelitis Diseases 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 210000005166 vasculature Anatomy 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/40—Detecting, measuring or recording for evaluating the nervous system
- A61B5/4058—Detecting, measuring or recording for evaluating the nervous system for evaluating the central nervous system
- A61B5/4064—Evaluating the brain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
- A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
- A61B3/102—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for optical coherence tomography [OCT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
- A61B3/0016—Operational features thereof
- A61B3/0025—Operational features thereof characterised by electronic signal processing, e.g. eye models
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
- A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
- A61B3/12—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for looking at the eye fundus, e.g. ophthalmoscopes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
- A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
- A61B3/12—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for looking at the eye fundus, e.g. ophthalmoscopes
- A61B3/1225—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for looking at the eye fundus, e.g. ophthalmoscopes using coherent radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
- A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
- A61B3/14—Arrangements specially adapted for eye photography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B34/00—Computer-aided surgery; Manipulators or robots specially adapted for use in surgery
- A61B34/25—User interfaces for surgical systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0071—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by measuring fluorescence emission
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/40—Detecting, measuring or recording for evaluating the nervous system
- A61B5/4076—Diagnosing or monitoring particular conditions of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B34/00—Computer-aided surgery; Manipulators or robots specially adapted for use in surgery
- A61B34/25—User interfaces for surgical systems
- A61B2034/256—User interfaces for surgical systems having a database of accessory information, e.g. including context sensitive help or scientific articles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/36—Image-producing devices or illumination devices not otherwise provided for
- A61B90/37—Surgical systems with images on a monitor during operation
- A61B2090/373—Surgical systems with images on a monitor during operation using light, e.g. by using optical scanners
- A61B2090/3735—Optical coherence tomography [OCT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/50—Supports for surgical instruments, e.g. articulated arms
- A61B2090/502—Headgear, e.g. helmet, spectacles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2576/00—Medical imaging apparatus involving image processing or analysis
- A61B2576/02—Medical imaging apparatus involving image processing or analysis specially adapted for a particular organ or body part
- A61B2576/026—Medical imaging apparatus involving image processing or analysis specially adapted for a particular organ or body part for the brain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0004—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by the type of physiological signal transmitted
- A61B5/0013—Medical image data
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0015—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by features of the telemetry system
- A61B5/0022—Monitoring a patient using a global network, e.g. telephone networks, internet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0062—Arrangements for scanning
- A61B5/0066—Optical coherence imaging
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Surgery (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Ophthalmology & Optometry (AREA)
- Neurology (AREA)
- Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physiology (AREA)
- Neurosurgery (AREA)
- Radiology & Medical Imaging (AREA)
- Human Computer Interaction (AREA)
- Robotics (AREA)
- Psychology (AREA)
- Signal Processing (AREA)
- Eye Examination Apparatus (AREA)
- Computer Networks & Wireless Communication (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
Abstract
Des systèmes et des procédés permettent de capturer la lumière réfléchie par le fond d'oeil d'un patient et de comparer les images obtenues à des images antérieures, afin de déterminer si le patient subit une inflammation ou une atrophie intra-oculaires.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762501482P | 2017-05-04 | 2017-05-04 | |
| US62/501,482 | 2017-05-04 | ||
| PCT/US2018/031171 WO2018204835A1 (fr) | 2017-05-04 | 2018-05-04 | Système de surveillance cérébrale |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3099238A1 true CA3099238A1 (fr) | 2018-11-08 |
Family
ID=64013868
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3099238A Pending CA3099238A1 (fr) | 2017-05-04 | 2018-05-04 | Systeme de surveillance cerebrale |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US10849547B2 (fr) |
| EP (1) | EP3618746A4 (fr) |
| CA (1) | CA3099238A1 (fr) |
| WO (1) | WO2018204835A1 (fr) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112021005394A2 (pt) | 2018-09-21 | 2021-06-15 | MacuLogix, Inc. | dispositivo utilizável na cabeça para medição de adaptação ao escuro em pelo menos um olho de um indivíduo, dispositivo para administrar um teste de diagnóstico oftálmico a um indivíduo, sistema de teste oftálmico, dispositivo eletrônico para teste oftálmico, sistema, sistema para medir adaptação ao escuro, vedação de luz para uso em um dispositivo utilizável na cabeça configurado para medir a adaptação ao escuro de um indivíduo, dispositivo utilizável na cabeça para administrar um teste oftálmico a um indivíduo, dispositivo utilizável na cabeça para administrar um teste de diagnóstico oftálmico a um indivíduo |
| WO2020123858A1 (fr) * | 2018-12-12 | 2020-06-18 | Tesseract Health, Inc. | Systèmes d'identification biométrique et dispositifs associés |
| CN110448266B (zh) * | 2018-12-29 | 2022-03-04 | 中国科学院宁波工业技术研究院慈溪生物医学工程研究所 | 随机激光共聚焦线扫描三维检眼镜及成像方法 |
| US11737665B2 (en) | 2019-06-21 | 2023-08-29 | Tesseract Health, Inc. | Multi-modal eye imaging with shared optical path |
| CA3142786A1 (fr) * | 2019-07-31 | 2021-02-04 | Xenon-Vr, Inc. | Systemes et procedes de test ophtalmique |
| WO2021151046A1 (fr) * | 2020-01-23 | 2021-07-29 | Retispec Inc. | Systèmes et procédés pour le diagnostic de maladies |
| TWI752616B (zh) * | 2020-09-04 | 2022-01-11 | 國立臺灣大學 | 訊號控制模組及低同調干涉儀 |
| CN113080842B (zh) | 2021-03-15 | 2023-06-27 | 青岛小鸟看看科技有限公司 | 一种头戴式视力检测设备、视力检测方法及电子设备 |
| USD1005288S1 (en) | 2022-03-03 | 2023-11-21 | Xenon Ophthalmics Inc. | Module for head mounted display |
| USD1019641S1 (en) | 2022-03-03 | 2024-03-26 | Xenon Ophthalmics Inc. | Headset |
| USD1005289S1 (en) | 2022-03-03 | 2023-11-21 | Xenon Ophthalmics Inc. | Headset |
| USD1021898S1 (en) | 2022-03-03 | 2024-04-09 | Xenon Ophthalmics Inc. | Module for head mounted display |
| DE102022203938A1 (de) * | 2022-04-22 | 2023-10-26 | Carl Zeiss Meditec Ag | Vorrichtung zur verlässlicheren Bestimmung biometrischer Messgrößen des gesamten Auges |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6485413B1 (en) * | 1991-04-29 | 2002-11-26 | The General Hospital Corporation | Methods and apparatus for forward-directed optical scanning instruments |
| US6003991A (en) * | 1996-02-17 | 1999-12-21 | Erik Scott Viirre | Eye examination apparatus and method for remote examination of a patient by a health professional |
| JP3837165B2 (ja) | 1996-08-16 | 2006-10-25 | アマーシャム バイオサイエンセズ ナイアガラ，インク． | ウェルプレート、ゲル及びブロットにおける検査用のディジタルイメージングシステム |
| DE19635998C1 (de) | 1996-09-05 | 1998-04-23 | Zeiss Carl Jena Gmbh | Anordnung zur Laserkoagulation von unterhalb der Fundusoberfläche liegenden Retinaschichten und Verfahren zur Ermittlung von Veränderungen in tiefen Gewebeschichten der Retina |
| US7431455B2 (en) * | 2005-03-22 | 2008-10-07 | Amo Manufacturing Usa, Llc | Pupilometer for pupil center drift and pupil size measurements at differing viewing distances |
| DE10047237A1 (de) * | 2000-09-23 | 2002-04-11 | Physoptics Opto Electronic Gmb | System zur Aufnahme des Netzhautreflexbildes |
| CA2390072C (fr) | 2002-06-28 | 2018-02-27 | Adrian Gh Podoleanu | Appareil de representation optique a pouvoir separateur en profondeur reglable et a fonctions multiples |
| GB2429522A (en) * | 2005-08-26 | 2007-02-28 | Univ Kent Canterbury | Optical mapping apparatus |
| WO2008133693A1 (fr) | 2007-05-01 | 2008-11-06 | Richard Spaide | Photographie par autofluorescence utilisant une caméra de fond d'œil |
| US20090213283A1 (en) * | 2008-02-27 | 2009-08-27 | Burlingame Robert G | Apparatus and method for adjustable variable transmissivity polarized eye glasses |
| US8348429B2 (en) * | 2008-03-27 | 2013-01-08 | Doheny Eye Institute | Optical coherence tomography device, method, and system |
| US20100278394A1 (en) * | 2008-10-29 | 2010-11-04 | Raguin Daniel H | Apparatus for Iris Capture |
| US8526472B2 (en) * | 2009-09-03 | 2013-09-03 | Axsun Technologies, Inc. | ASE swept source with self-tracking filter for OCT medical imaging |
| DE102010032138A1 (de) * | 2010-07-24 | 2012-01-26 | Carl Zeiss Meditec Ag | OCT-basiertes, ophthalmologisches Messsytem |
| US20130229620A1 (en) * | 2012-03-05 | 2013-09-05 | Daniel X. Hammer | Enhanced Sensitivity Line Field Detection |
| US8999292B2 (en) | 2012-05-01 | 2015-04-07 | Translatum Medicus Inc. | Methods for treating and diagnosing blinding eye diseases |
| EP2967469B1 (fr) * | 2013-03-15 | 2021-11-24 | Praevium Research, Inc. | Système de tomographie par cohérence optique à source balayée |
| US9888841B2 (en) | 2013-08-10 | 2018-02-13 | Joshua Noel Hogan | Head-mounted optical coherence tomography |
| US20150223683A1 (en) * | 2014-02-10 | 2015-08-13 | Labyrinth Devices, Llc | System For Synchronously Sampled Binocular Video-Oculography Using A Single Head-Mounted Camera |
| US9723978B2 (en) * | 2014-03-31 | 2017-08-08 | Nidek Co., Ltd. | Fundus photography device |
| DE102014008293A1 (de) | 2014-06-03 | 2015-12-03 | Ralf Steffens | Leistungsanpassung bei einem Spindelkompressor |
| CN106572792B (zh) * | 2014-06-05 | 2020-03-06 | 海德堡大学 | 用于多光谱成像的方法和部件 |
| EP3026426A1 (fr) * | 2014-11-26 | 2016-06-01 | Universität Stuttgart | Sonde de mesure, appareil et procédé de réflexion atténuée sans marqueur par spectroscopie infrarouge |
| KR101932368B1 (ko) * | 2015-01-13 | 2019-03-20 | 가부시키가이샤 리코 | 헤드 마운트 표시 장치 및 표시 방법 |
| US10666928B2 (en) * | 2015-02-06 | 2020-05-26 | The University Of Akron | Optical imaging system and methods thereof |
| AU2016233268B2 (en) * | 2015-03-16 | 2020-05-14 | Magic Leap, Inc. | Methods and systems for diagnosing and treating health ailments |
| US10539812B2 (en) * | 2015-05-01 | 2020-01-21 | Switch Materials Inc. | Eyewear control system and method, and an eyewear device |
| US9457253B1 (en) | 2015-06-26 | 2016-10-04 | Dacks Rodriguez | Vision training system |
| JP6490519B2 (ja) * | 2015-06-30 | 2019-03-27 | 株式会社トプコン | 眼科用顕微鏡システム |
| WO2017091909A1 (fr) * | 2015-12-03 | 2017-06-08 | Ophthalight Digital Solutions Inc. | Dispositif portatif de test de réponse oculaire et procédés d'utilisation |
| EP3448233A4 (fr) * | 2016-04-30 | 2019-05-08 | Envision Diagnostics, Inc. | Dispositifs médicaux, systèmes, et procédés d'exécution d'examens des yeux au moyen d'affichages comprenant des miroirs de balayage mems |
-
2018
- 2018-05-04 CA CA3099238A patent/CA3099238A1/fr active Pending
- 2018-05-04 WO PCT/US2018/031171 patent/WO2018204835A1/fr unknown
- 2018-05-04 US US15/971,740 patent/US10849547B2/en active Active
- 2018-05-04 EP EP18793948.3A patent/EP3618746A4/fr active Pending
-
2020
- 2020-11-30 US US17/106,962 patent/US11826159B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3618746A1 (fr) | 2020-03-11 |
| US20210186408A1 (en) | 2021-06-24 |
| WO2018204835A1 (fr) | 2018-11-08 |
| WO2018204835A4 (fr) | 2019-01-03 |
| US11826159B2 (en) | 2023-11-28 |
| EP3618746A4 (fr) | 2021-06-16 |
| US10849547B2 (en) | 2020-12-01 |
| US20180317832A1 (en) | 2018-11-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11826159B2 (en) | Brain monitoring system | |
| US12193742B2 (en) | Optical coherence tomography-based ophthalmic testing methods, devices and systems | |
| US10945597B2 (en) | Optical coherence tomography-based ophthalmic testing methods, devices and systems | |
| JP7414935B2 (ja) | 健康を損う疾病を診断して治療する方法及びシステム | |
| EP2835097A1 (fr) | Appareil d'imagerie ophtalmologique | |
| WO2010117386A1 (fr) | Procédés, dispositifs et systèmes d'examen ophtalmique | |
| US11911103B2 (en) | Personalized patient interface for ophthalmic devices | |
| WO2011143387A2 (fr) | Systèmes et procédés de tomographie à cohérence optique intégrés | |
| CN112740098A (zh) | 眼睛的屈光不正的变化的确定 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20230502 |
|
| EEER | Examination request |
Effective date: 20230502 |
|
| EEER | Examination request |
Effective date: 20230502 |